0

Liver Disease Collection
 41-60 of 955 Articles
Editorials |  21 March 2006
Telithromycin
Michelle Turner, PharmD; G. Ralph Corey, MD; Elias Abrutyn, MD
Ann Intern Med. 2006;144(6):447-448. doi:10.7326/0003-4819-144-6-200603210-00014
Articles |  21 February 2006
Zoledronic Acid Prevents Bone Loss after Liver Transplantation: A Randomized, Double-Blind, Placebo-Controlled Trial
Bronwyn A.L. Crawford, MBBS, PhD; Cherie Kam, MPH, GDipScMed; Julie Pavlovic, RN; et al.
Ann Intern Med. 2006;144(4):239-248. doi:10.7326/0003-4819-144-4-200602210-00005
Articles |  17 January 2006
Brief Communication: Tamoxifen Therapy for Nonmalignant Retroperitoneal Fibrosis
Eric F.H. van Bommel, MD, PhD; Tadek R. Hendriksz, MD; Antonius W.L.C. Huiskes, MD; et al.
Ann Intern Med. 2006;144(2):101-106. doi:10.7326/0003-4819-144-2-200601170-00007
Editorials |  15 November 2005
Dangerous Liaisons: The Metabolic Syndrome and Nonalcoholic Fatty Liver Disease
Elizabeth E. Powell, MBBS, PhD; Julie R. Jonsson, BSc, PhD; Andrew D. Clouston, MBBS, PhD
Ann Intern Med. 2005;143(10):753-754. doi:10.7326/0003-4819-143-10-200511150-00015
Articles |  15 November 2005
The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease
Masahide Hamaguchi, MD; Takao Kojima, MD; Noriyuki Takeda, MD; et al.
Ann Intern Med. 2005;143(10):722-728. doi:10.7326/0003-4819-143-10-200511150-00009
Current Clinical Issues |  21 June 2005
Liver Cancer on the Rise
Jennifer Fisher Wilson
Ann Intern Med. 2005;142(12_Part_1):1029-1032. doi:10.7326/0003-4819-142-12 Part 1-200506210-00024
Articles |  17 May 2005
Treatment Alternatives for Chronic Hepatitis B Virus Infection: A Cost-Effectiveness Analysis
Fasiha Kanwal, MD, MSHS; Ian M. Gralnek, MD, MSHS; Paul Martin, MD; et al.
Ann Intern Med. 2005;142(10):821-831. doi:10.7326/0003-4819-142-10-200505170-00007
Reviews |  15 March 2005
Recommendations for the Diagnosis and Treatment of the Acute Porphyrias
Karl E. Anderson, MD; Joseph R. Bloomer, MD; Herbert L. Bonkovsky, MD; et al.
Ann Intern Med. 2005;142(6):439-450. doi:10.7326/0003-4819-142-6-200503150-00010
Articles |  15 February 2005
A Randomized, Controlled Trial of Combination Therapy for Chronic Hepatitis B: Comparing Pegylated Interferon-α2b and Lamivudine with Lamivudine Alone
Henry Lik-Yuen Chan, MD; Nancy Wai-Yee Leung, MD; Alex Yui Hui, MB, BChir; et al.
Ann Intern Med. 2005;142(4):240-250. doi:10.7326/0003-4819-142-4-200502150-00006
Articles |  2 March 2004
Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C: A Randomized Study of Treatment Duration and Ribavirin Dose
Stephanos J. Hadziyannis, MD; Hoel Sette, MD; Timothy R. Morgan, MD; et al.
Ann Intern Med. 2004;140(5):346-355. doi:10.7326/0003-4819-140-5-200403020-00010
Reviews |  2 March 2004
Heterogeneous Virologic Response Rates to Interferon-Based Therapy in Patients with Chronic Hepatitis C: Who Responds Less Well?
Stefan Zeuzem, MD
Ann Intern Med. 2004;140(5):370-381. doi:10.7326/0003-4819-140-8-200404200-00009
Articles |  18 November 2003 FREE
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
Hashem B. El-Serag, MD, MPH; Jessica A. Davila, PhD; Nancy J. Petersen, PhD; et al.
Ann Intern Med. 2003;139(10):817-823. doi:10.7326/0003-4819-139-10-200311180-00009
Reviews |  21 October 2003
Delayed Drug Hypersensitivity Reactions
Werner J. Pichler, MD
Ann Intern Med. 2003;139(8):683-693. doi:10.7326/0003-4819-139-8-200310210-00012
Brief Communications |  16 September 2003
Hepatic Injury in 12 Patients Taking the Herbal Weight Loss Aids Chaso or Onshido
Masayuki Adachi, MD; Hidetsugu Saito, MD, PhD; Hisashi Kobayashi, MD; et al.
Ann Intern Med. 2003;139(6):488-492. doi:10.7326/0003-4819-139-6-200309160-00012
Articles |  5 August 2003
The Effect of Selective Intestinal Decontamination on the Hyperdynamic Circulatory State in Cirrhosis: A Randomized Trial
Brindhesha Rasaratnam , MBBS, FRACP; David Kaye , MBBS, FRACP, PhD; Garry Jennings , MBBS, FRACP, MD; et al.
Ann Intern Med. 2003;139(3):186-193. doi:10.7326/0003-4819-139-3-200308050-00008
Reviews |  1 July 2003 FREE
Test Characteristics of α-Fetoprotein for Detecting Hepatocellular Carcinoma in Patients with Hepatitis C: A Systematic Review and Critical Analysis
Samir Gupta, MD; Stephen Bent, MD; Jeffrey Kohlwes, MD, MPH
Ann Intern Med. 2003;139(1):46-50. doi:10.7326/0003-4819-139-1-200307010-00012
Articles |  15 April 2003
Serum Ferritin Level Predicts Advanced Hepatic Fibrosis among U.S. Patients with Phenotypic Hemochromatosis
Elizabeth D. Morrison, MD; David J. Brandhagen, MD; Pradyumna D. Phatak, MD; et al.
Ann Intern Med. 2003;138(8):627-633. doi:10.7326/0003-4819-138-8-200304150-00008
Articles |  18 February 2003
Interferon Therapy after Tumor Ablation Improves Prognosis in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus
Yasushi Shiratori, MD; Shuichiro Shiina, MD; Takuma Teratani, MD; et al.
Ann Intern Med. 2003;138(4):299-306. doi:10.7326/0003-4819-138-4-200302180-00008
Brief Communications |  4 February 2003
Treatment of Chronic Hepatitis C in a State Correctional Facility
Scott A. Allen, MD; Anne C. Spaulding, MD; Albert M. Osei, MD; et al.
Ann Intern Med. 2003;138(3):187-190. doi:10.7326/0003-4819-138-3-200302040-00010
Editorials |  4 February 2003
Adopting More Systematic Approaches to Hepatitis C Treatment in Correctional Facilities
Theodore M. Hammett, PhD
Ann Intern Med. 2003;138(3):235-236. doi:10.7326/0003-4819-138-3-200302040-00021
Advertisement

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)